Abstract
A total of 90 patients has been treated with Treosulfan. The minimum follow-up period was 6 months. Distribution according to age and clinical stages corresponds to what is usually found. The treatment with Treosulfan was given in interrupted causes. The only serious side effect is a depression of the bone-marrow function. Apart from this, Treosulfan is well tolerated and in most cases the treatment can be carried out in the open ward. It is striking that the general condition of the patients very often was improved considerably. Five patients suffering from disseminated cancer apparently were cured. An excellent effect on ascites was seen since a complete disappearance of ascites was seen in 17 out of 27 patients with serous carcinoma and a transient improvement in six. There was hardly any effect of the treatment of the patients in the terminal stage of the disease. In stage III the average survival time for patients who died of the disease was proportional with the degree of response, viz.: Excellent r...
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
